43. Chronic Fatigue Virus Vanishes on Closer Look

After years of debate, scientists finally agree that the disease is not linked to the XMRV virus.

By Mary Beth Griggs
Jan 7, 2013 6:00 AMNov 12, 2019 5:56 AM

Newsletter

Sign up for our email newsletter for the latest science news
 

Three years ago, a virus called XMRV (xenotropic murine leukemia virus–related virus) made headlines when a researcher flagged it as a potential cause of chronic fatigue syndrome, attaching a concrete cause to a mysterious disease. Earlier work hinted that XMRV causes prostate cancer as well. But last year the case fell apart, as the virus was cleared on both counts by two separate studies, both published on September 18.

Soon after Judy Mikovits, then a researcher at the Whittemore Peterson Institute for Neuro-Immune Disease in Reno, Nevada, published her original 2009 results in Science, other researchers failed to replicate her findings and started raising concerns. So Columbia University virus hunter W. Ian Lipkin coordinated with three separate labs to determine conclusively whether XMRV is linked to chronic fatigue. The investigation found no evidence of the retrovirus in any of the study's 293 subjects, whether they had chronic fatigue syndrome or not.

In fact, an independent study had concluded that XMRV was the result of the recombination of two mouse proviruses sometime between 1993 and 1996—an artifact, not a real virus. It is likely that the studies originally connecting XMRV to human disease used samples that were contaminated with the lab-generated virus.

1 free article left
Want More? Get unlimited access for as low as $1.99/month

Already a subscriber?

Register or Log In

1 free articleSubscribe
Discover Magazine Logo
Want more?

Keep reading for as low as $1.99!

Subscribe

Already a subscriber?

Register or Log In

More From Discover
Stay Curious
Join
Our List

Sign up for our weekly science updates.

 
Subscribe
To The Magazine

Save up to 40% off the cover price when you subscribe to Discover magazine.

Copyright © 2024 LabX Media Group